GB, including the AHVLA's Veterinary Investigation Diagnosis and Analysis (VIDA) process. These threats are assessed by the CEG and potentially significant ones that could have an impact on our livestock industry are reviewed by the Veterinary Risk Group, a multiagency UK group that further assesses, characterises and ranks each threat through a standardised peer-reviewed riskbased approach. Thirdly, this ranking is used to inform the response required, including if there is a need for active surveillance, which is then developed. With respect to BVD, occurrence of BVD type 2 in the UK in 2007 prompted active surveillance which is ongoing, and the recent outbreaks in continental Europe confirm its value given continual trade. All of the samples submitted for testing with the AHVLA's PCR which can differentiate BVD-1,-2 and border disease, and all positive Erns antigen tests, are further screened by PCR to confirm the type. Further sequencing is only undertaken on an individual case basis. With regard to trade, non-notifiable endemic diseases remain the responsibility of the importer, who should take advice from their veterinarian about the potential risks to their herds (and beyond) from importation. Mr Kerby's initiative is very welcome, especially as the emphasis in surveillance in GB moves more towards a more collaborative approach.